Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeted nanoparticles modify neutrophil function in vivo.
Völs S, Kaisar-Iluz N, Shaul ME, Ryvkin A, Ashkenazy H, Yehuda A, Atamneh R, Heinberg A, Ben-David-Naim M, Nadav M, Hirsch S, Mitesser V, Salpeter SJ, Dzikowski R, Hayouka Z, Gershoni JM, Fridlender ZG, Granot Z. Völs S, et al. Among authors: gershoni jm. Front Immunol. 2022 Oct 5;13:1003871. doi: 10.3389/fimmu.2022.1003871. eCollection 2022. Front Immunol. 2022. PMID: 36275643 Free PMC article.
Antibody Recognition of CD4-Induced Open HIV-1 Env Trimers.
Yang Z, Dam KA, Gershoni JM, Zolla-Pazner S, Bjorkman PJ. Yang Z, et al. Among authors: gershoni jm. J Virol. 2022 Dec 21;96(24):e0108222. doi: 10.1128/jvi.01082-22. Epub 2022 Nov 30. J Virol. 2022. PMID: 36448805 Free PMC article.
Tumor-reactive antibodies evolve from non-binding and autoreactive precursors.
Mazor RD, Nathan N, Gilboa A, Stoler-Barak L, Moss L, Solomonov I, Hanuna A, Divinsky Y, Shmueli MD, Hezroni H, Zaretsky I, Mor M, Golani O, Sabah G, Jakobson-Setton A, Yanichkin N, Feinmesser M, Tsoref D, Salman L, Yeoshoua E, Peretz E, Erlich I, Cohen NM, Gershoni JM, Freund N, Merbl Y, Yaari G, Eitan R, Sagi I, Shulman Z. Mazor RD, et al. Among authors: gershoni jm. Cell. 2022 Mar 31;185(7):1208-1222.e21. doi: 10.1016/j.cell.2022.02.012. Epub 2022 Mar 18. Cell. 2022. PMID: 35305314 Free article.
Functional reconstitution of the MERS CoV receptor binding motif.
Uppalapati L, Roitburd-Berman A, Weiss-Ottolenghi Y, Graham BS, Dimitrov DS, Ying T, Failayev H, Tsfadia Y, Gershoni JM. Uppalapati L, et al. Among authors: gershoni jm. Mol Immunol. 2022 May;145:3-16. doi: 10.1016/j.molimm.2022.03.006. Epub 2022 Mar 4. Mol Immunol. 2022. PMID: 35272105 Free PMC article.
Motifier: An IgOme Profiler Based on Peptide Motifs Using Machine Learning.
Ashkenazy H, Avram O, Ryvkin A, Roitburd-Berman A, Weiss-Ottolenghi Y, Hada-Neeman S, Gershoni JM, Pupko T. Ashkenazy H, et al. Among authors: gershoni jm. J Mol Biol. 2021 Jul 23;433(15):167071. doi: 10.1016/j.jmb.2021.167071. Epub 2021 May 28. J Mol Biol. 2021. PMID: 34052285 Free PMC article.
Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors.
Mor M, Werbner M, Alter J, Safra M, Chomsky E, Lee JC, Hada-Neeman S, Polonsky K, Nowell CJ, Clark AE, Roitburd-Berman A, Ben-Shalom N, Navon M, Rafael D, Sharim H, Kiner E, Griffis ER, Gershoni JM, Kobiler O, Leibel SL, Zimhony O, Carlin AF, Yaari G, Dessau M, Gal-Tanamy M, Hagin D, Croker BA, Freund NT. Mor M, et al. Among authors: gershoni jm. PLoS Pathog. 2021 Feb 11;17(2):e1009165. doi: 10.1371/journal.ppat.1009165. eCollection 2021 Feb. PLoS Pathog. 2021. PMID: 33571304 Free PMC article.
Multi-Clonal Live SARS-CoV-2 In Vitro Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors.
Mor M, Werbner M, Alter J, Safra M, Chomsky E, Hada-Neeman S, Polonsky K, Nowell CJ, Clark AE, Roitburd-Berman A, Shalom NB, Navon M, Rafael D, Sharim H, Kiner E, Griffis E, Gershoni JM, Kobiler O, Leibel SL, Zimhony O, Carlin AF, Yaari G, Dassau M, Gal-Tanamy M, Hagin D, Croker BA, Freund NT. Mor M, et al. Among authors: gershoni jm. bioRxiv [Preprint]. 2020 Oct 6:2020.10.06.323634. doi: 10.1101/2020.10.06.323634. bioRxiv. 2020. PMID: 33052341 Free PMC article. Updated. Preprint.
98 results